
Merrimack Pharmaceuticals (MACK)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Merrimack Pharmaceuticals (MACK) Stock
Start investing in Merrimack Pharmaceuticals (MACK)
About Merrimack Pharmaceuticals (MACK)
Market cap | $223.74M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 192.63K |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -8.91x |
Today's range | — |
Debt / equity | — |
52 week range | $11.53 - $15.89 |
5 year debt / equity | — |
Beta (LTM) | 0.15x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Aug 1, 2025 |
Dividend payable date | — |
Merrimack Pharmaceuticals Stock Rating
Merrimack Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy MACK stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in MACK stock
Navigate to the Explore page. Then, type MACK into the search bar. When you see MACK stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased MACK stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Merrimack Pharmaceuticals Stock Earnings
The value each MACK share was expected to gain vs. the value that each MACK share actually gained.
Merrimack Pharmaceuticals (MACK) reported earnings per share (EPS) of $0, — estimates of $0 by —. In the same quarter last year, Merrimack Pharmaceuticals's earnings per share (EPS) was $0. Merrimack Pharmaceuticals is expected to release next earnings on 08/01/2025, with an earnings per share (EPS) estimate of $0.